Pharmacogenetic determinants of variability in lipid-lowering response to pravastatin therapy
- 18 August 2006
- journal article
- Published by Springer Science and Business Media LLC in Journal of Human Genetics
- Vol. 51 (9), 822-826
- https://doi.org/10.1007/s10038-006-0025-1
Abstract
Journal of Human Genetics, official journal of the Japan Society of Human Genetics, publishes original articles and reviews on all aspects of human genetics, including medical genetics and genomicsKeywords
This publication has 18 references indexed in Scilit:
- A promoter polymorphism in cholesterol 7α-hydroxylase interacts with apolipoprotein E genotype in the LDL-lowering response to atorvastatinAtherosclerosis, 2005
- Identification of the Hepatic Efflux Transporters of Organic Anions Using Double-Transfected Madin-Darby Canine Kidney II Cells Expressing Human Organic Anion-Transporting Polypeptide 1B1 (OATP1B1)/Multidrug Resistance-Associated Protein 2, OATP1B1/Multidrug Resistance 1, and OATP1B1/Breast Cancer Resistance ProteinJournal of Pharmacology and Experimental Therapeutics, 2005
- Pharmacogenetic Study of Statin Therapy and Cholesterol ReductionJAMA, 2004
- ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatinJournal of Lipid Research, 2004
- Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotypeJCI Insight, 2002
- Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotypeJCI Insight, 2002
- Polymorphisms in the ABCC2 (cMOAT/MRP2) Gene Found in 72 Established Cell Lines Derived from Japanese Individuals: An Association between Single Nucleotide Polymorphisms in the 5′-Untranslated Region and Exon 28: Table 1Drug Metabolism and Disposition, 2002
- Therapy with HMG CoA reductase inhibitors: characteristics of the long-term permanence of hypocholesterolemic activityAtherosclerosis, 1995
- Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapyAtherosclerosis, 1995
- Effect of apolipoprotein E polymorphism and Xbal polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non‐familial hypercholesterolaemiaJournal of Internal Medicine, 1991